Amendment of regulation 229 (exemption for supply by national health services bodies and local authorities)U.K.
This section has no associated Explanatory Memorandum
[F1187. In regulation 229(3), for sub-paragraph (f) substitute—
“(f)when the product is supplied—
(i)in Northern Ireland, a UKMA(NI), UKMA(UK), EU marketing authorisation, Article 126a authorisation, certificate of registration, THR(NI) or THR(UK), or
(ii)in Great Britain, a UKMA(GB), UKMA(UK), certificate of registration, THR(GB) or THR(UK),
is in force in relation to it.”.]
Textual Amendments
F1Reg. 187 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 141
Commencement Information
I1Reg. 187 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1